Total Payments
$4,330
2024 Payments
$1,565
Companies
25
Transactions
103
Medicare Patients
15,326
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$2,732 (63.1%)
Consulting$1,220 (28.2%)
Education$287.25 (6.6%)
Other$90.55 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,732 | 97 | 63.1% |
| Consulting Fee | $1,220 | 1 | 28.2% |
| Education | $287.25 | 4 | 6.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $90.55 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $1,311 | 2 | $0 (2019) |
| ABBVIE INC. | $665.84 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $416.78 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $283.38 | 11 | $0 (2024) |
| UCB, Inc. | $217.44 | 5 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $167.30 | 8 | $0 (2024) |
| Incyte Corporation | $124.11 | 5 | $0 (2024) |
| Genentech USA, Inc. | $122.92 | 1 | $0 (2018) |
| Biofrontera Inc. | $117.43 | 2 | $0 (2024) |
| Amgen Inc. | $93.94 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,565 | 49 | ABBVIE INC. ($454.64) |
| 2023 | $948.84 | 43 | ABBVIE INC. ($190.16) |
| 2022 | $36.33 | 2 | ABBVIE INC. ($21.04) |
| 2021 | $100.11 | 2 | SANOFI-AVENTIS U.S. LLC ($72.00) |
| 2020 | $124.81 | 2 | Janssen Biotech, Inc. ($99.99) |
| 2019 | $1,432 | 4 | Celgene Corporation ($1,311) |
| 2018 | $122.92 | 1 | Genentech USA, Inc. ($122.92) |
All Payment Transactions
103 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.15 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Inflammation & Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.27 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Immunology | ||||||
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.31 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $98.75 | General |
| Category: DERMATOLOGY | ||||||
| 09/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.49 | General |
| Category: Dermatology | ||||||
| 09/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Dermatology | ||||||
| 09/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Dermatology | ||||||
| 08/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Immunology | ||||||
| 08/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2024 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 08/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.49 | General |
| Category: Immunology | ||||||
| 07/24/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) | Food and Beverage | In-kind items and services | $31.56 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $45.08 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 5,960 | 10,968 | $1.0M | $478,060 |
| 2022 | 35 | 4,239 | 8,177 | $842,112 | $266,890 |
| 2021 | 32 | 3,284 | 5,835 | $606,772 | $200,201 |
| 2020 | 25 | 1,843 | 2,886 | $300,103 | $94,448 |
Total Patients
15,326
Total Services
27,866
Medicare Billing
$1.0M
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 975 | 1,311 | $180,918 | $87,625 | 48.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 740 | 932 | $148,188 | $65,566 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 418 | 600 | $117,450 | $56,716 | 48.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 921 | 1,254 | $126,027 | $45,954 | 36.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 485 | 485 | $82,208 | $38,412 | 46.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 167 | 206 | $56,084 | $26,094 | 46.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 283 | 322 | $55,867 | $25,786 | 46.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 206 | 206 | $52,170 | $22,882 | 43.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 715 | 4,342 | $43,420 | $22,657 | 52.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 291 | 468 | $37,791 | $18,723 | 49.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 278 | 299 | $25,415 | $12,414 | 48.8% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 16 | 31 | $18,228 | $9,500 | 52.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 54 | 62 | $15,655 | $7,690 | 49.1% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 40 | 41 | $12,075 | $6,005 | 49.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 53 | 56 | $11,130 | $5,438 | 48.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 109 | 109 | $12,017 | $5,278 | 43.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 23 | 23 | $10,839 | $5,165 | 47.7% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 27 | 27 | $7,769 | $4,104 | 52.8% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 17 | 28 | $8,260 | $3,155 | 38.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 20 | $7,560 | $2,116 | 28.0% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $3,771 | $1,988 | 52.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 25 | 33 | $2,838 | $1,262 | 44.5% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 21 | 22 | $3,009 | $1,172 | 39.0% |
| 40490 | Biopsy of lip | Office | 2023 | 12 | 12 | $2,304 | $785.13 | 34.1% |
| 69100 | Biopsy of ear | Office | 2023 | 15 | 15 | $2,273 | $778.50 | 34.3% |
About Dr. Anh Pham, M.D
Dr. Anh Pham, M.D is a Dermatopathology healthcare provider based in Hampton, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2015. The National Provider Identifier (NPI) number assigned to this provider is 1932582467.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anh Pham, M.D has received a total of $4,330 in payments from pharmaceutical and medical device companies, with $1,565 received in 2024. These payments were reported across 103 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,732).
As a Medicare-enrolled provider, Pham has provided services to 15,326 Medicare beneficiaries, totaling 27,866 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Dermatology
- Location Hampton, VA
- Active Since 07/01/2015
- Last Updated 03/12/2025
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1932582467
Products in Payments
- Otezla (Drug) $1,374
- DUPIXENT (Biological) $447.12
- RINVOQ (Biological) $402.83
- TREMFYA (Drug) $399.15
- SKYRIZI (Biological) $241.97
- Bimzelx (Biological) $139.19
- OPZELURA (Drug) $124.11
- Erivedge (Biological) $122.92
- AMELUZ (Drug) $117.43
- Apligraf (Device) $90.55
- Zoryve (Drug) $82.97
- Cimzia (Drug) $78.25
- ADBRY (Biological) $71.61
- VTAMA (Drug) $65.21
- KEYTRUDA (Biological) $51.48
- AKLIEF (Drug) $34.50
- Sotyktu (Drug) $33.42
- CIBINQO (Drug) $33.03
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $31.56
- Enbrel (Biological) $31.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.